Testing effectiveness (Phase 2)Study completedNCT04540042
What this trial is testing
Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)
Who this might be right for
AsthmaChronic Obstructive Pulmonary Disease
Tetherex Pharmaceuticals Corporation 61